Selenium and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Selenium (selenium), especially for people who are female, 50-59 old, also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Atelectasis when taking Selenium. It is created by eHealthMe based on reports of 5,049 people who have side effects when taking Selenium from the FDA, and is updated regularly.

What is Selenium?

Selenium has active ingredients of selenium. It is often used in vitamin supplementation. eHealthMe is studying from 5,312 Selenium users. Check the latest studies of Selenium.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,514 drugs and 1,613 conditions by eHealthMe. Check the latest studies of Atelectasis.

On Oct, 27, 2025

5,049 people reported to have side effects when taking Selenium.
Among them, 63 people (1.25%) have Atelectasis.

Among these 63 people:

What is the gender of people who have Atelectasis when taking Selenium? *

female: 58.06 %
male: 41.94 %

What is the age of people who have Atelectasis when taking Selenium? *

What are other drugs people take besides Selenium? *

What are other side effects people have besides Atelectasis? *

Osteonecrosis Of Jaw (death of bone of jaw): 57 people, 90.48%
Pain: 55 people, 87.30%
Stress And Anxiety: 55 people, 87.30%
Injury: 54 people, 85.71%
Spinal Osteoarthritis (joint cartilage loss in spine): 43 people, 68.25%
Depression: 41 people, 65.08%
Oedema Peripheral (superficial swelling): 39 people, 61.90%
Diarrhea: 38 people, 60.32%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 37 people, 58.73%
Anaemia (lack of blood): 36 people, 57.14%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 20 people, 31.75%
Bone Density Abnormal: 11 people, 17.46%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 9 people, 14.29%
Bone Density Decreased: 7 people, 11.11%
Bone Cancer Metastatic: 5 people, 7.94%
Osteoporosis (bones weak and more likely to break): 5 people, 7.94%
Breast Cancer: 5 people, 7.94%
Osteomyelitis (infection of bone): 4 people, 6.35%
Birth Control: 4 people, 6.35%
Bone Loss: 4 people, 6.35%

* Approximation only. Some reports may have incomplete information.

Do you take Selenium and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Selenium:

Selenium (5,312 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Selenium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,514 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,613 conditions)

Drugs similar to Selenium and Atelectasis :

How the study uses the data?

The study uses data from the FDA. It is based on selenium (the active ingredients of Selenium) and Selenium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.